Correlation Between CureVac NV and Denali Therapeutics
Can any of the company-specific risk be diversified away by investing in both CureVac NV and Denali Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CureVac NV and Denali Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between CureVac NV and Denali Therapeutics, you can compare the effects of market volatilities on CureVac NV and Denali Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CureVac NV with a short position of Denali Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of CureVac NV and Denali Therapeutics.
Diversification Opportunities for CureVac NV and Denali Therapeutics
-0.55 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between CureVac and Denali is -0.55. Overlapping area represents the amount of risk that can be diversified away by holding CureVac NV and Denali Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Denali Therapeutics and CureVac NV is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CureVac NV are associated (or correlated) with Denali Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Denali Therapeutics has no effect on the direction of CureVac NV i.e., CureVac NV and Denali Therapeutics go up and down completely randomly.
Pair Corralation between CureVac NV and Denali Therapeutics
Given the investment horizon of 90 days CureVac NV is expected to under-perform the Denali Therapeutics. In addition to that, CureVac NV is 1.09 times more volatile than Denali Therapeutics. It trades about -0.02 of its total potential returns per unit of risk. Denali Therapeutics is currently generating about 0.0 per unit of volatility. If you would invest 2,591 in Denali Therapeutics on October 16, 2024 and sell it today you would lose (632.00) from holding Denali Therapeutics or give up 24.39% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
CureVac NV vs. Denali Therapeutics
Performance |
Timeline |
CureVac NV |
Denali Therapeutics |
CureVac NV and Denali Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with CureVac NV and Denali Therapeutics
The main advantage of trading using opposite CureVac NV and Denali Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CureVac NV position performs unexpectedly, Denali Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Denali Therapeutics will offset losses from the drop in Denali Therapeutics' long position.CureVac NV vs. BJs Restaurants | CureVac NV vs. Pinterest | CureVac NV vs. Biglari Holdings | CureVac NV vs. Radcom |
Denali Therapeutics vs. Ginkgo Bioworks Holdings | Denali Therapeutics vs. CureVac NV | Denali Therapeutics vs. Iovance Biotherapeutics | Denali Therapeutics vs. Krystal Biotech |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Other Complementary Tools
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
CEOs Directory Screen CEOs from public companies around the world | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |